CH EPL (R5)
1.0.0 - trial-use Switzerland flag

This page is part of the CH EPL (R5) (v1.0.0: DSTU 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions

Example RegulatedAuthorization: Reimbursement SL 21203 1 Pre-Filled Pen

CH - EPL Reimbursement SL

  • FOPHDossierNumber: FOPH Dossier Number/21203
  • status: Reimbursed
  • statusDate: 2021-06-01
  • expiryDate: 2100-12-31
  • listingStatus: Listed
  • listingPeriod: 2021-06-01 --> 2100-12-31
  • firstListingDate: 2021-06-01
  • costShare: 10
  • productType: Originator product
  • gamme: Parenteral

CH - EPL Product Price

  • value: CHF371.10 (CHF)
  • type: Ex-factory price
  • changeType: Normal price mutation
  • changeDate: 2023-12-01

CH - EPL Product Price

  • value: CHF419.95 (CHF)
  • type: Retail price
  • changeType: VAT-change
  • changeDate: 2023-12-01

subject: PackagedProductDefinition: identifier = http://fhir.ch/ig/ch-epl/sid/pcid#Clinical Product Identifier#CH-7601001010604-6783101-001; containedItemQuantity = 1 Pre-filled pen; description = ABRILADA Inj Lös 40 mg/0.8ml Fertpen 1 x 0.8 ml

type: Reimbursement SL

Indications

-ExtensionReference
*, , , , , , ClinicalUseDefinition: type = indication

holder: Organization Pfizer AG

Generated Narrative: Organization #holder-Pfizer-AG

identifier: LOC Identifier/100015286, GLN Identifier/7601001010604

name: Pfizer AG